Skip to main content
OpenTrials
Completed

NCT Number: NCT02028143

ICE: Intracardiac Ultrasound Within the Left Atrium During Radiofrequency Ablation of Nonvalvular Atrial Fibrillation

Imaging Real Time within the Left atrial chamber Enhances safety and efficacy of Radiofrequency Ablation of Atrial Fibrillation

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Wellmont CVA Heart Institute

Kingsport, Tennessee, 37660, United States

About this study

Atrial fibrillation is the most common rhythm disturbance affecting the human population.

  • Its prevalence increases with age and can be found in >8% of humans over the age of eighty;
  • Radiofrequency ablation for drug refractory nonvalvular atrial fibrillation has become a common therapy available to patients. It has been shown to be both efficacious and cost effective;
  • The standard approach to atrial fibrillation involves electrical isolation of the pulmonary veins (PVI) from the rest of the atrium chamber. This involves moving a 3.5mm tip ablation catheter point to point around the PV structures until an encircling ablation line is formed. This can be made difficult by not knowing if the tip is in good contact with the atrial tissue. In addition the esophagus is a posterior lying structure and injury to the esophagus by ablating the overlying tissue has been reported, at times fatal;
  • Currently, intracardiac imaging of the left atrium has FDA approval in the right atrial chamber. This leads to difficulty in visualizing tip tissue interface, and important left sided structures such as carina, ligaments, and esophagus. By placing the tip of the ICE catheter in the left atrium, enhanced visualization of the tip tissue interface may lead to more effective ablation points, fewer needed ablation points, and enhanced safety by avoiding placement over adjacent noncardiac structures.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 80 years
  • Recommended for radiofrequency ablation of nonvalvular atrial fibrillation

Exclusion criteria

  • none

Treatment and study plan

Biosense Webster irrigated tip catheter

Device

The second group (study group) will have the ICE catheter placed through one of two existing 8F sheaths already in the left atrium. The ICE catheter will be exchanged in the sheath utilizing the lasso multipolar mapping catheter during left pulmonary vein ablation lines. During exchange, suction and irrigation techniques will be utilized to avoid any air or thrombus embolization. All patients will have standard anticoagulation during the procedure with heparin infusion adjusted to an activated clotting time (ACT) of 350-400. The left sided ICE catheter will be adjusted to visualize left sided structures, ablation tip and tissue interface, and adjacent noncardiac structures such as the esophagus during radiofrequency ablation of the left pulmonary vein system.

Other names: 3.5mm Biosense Webster irrigated tip catheter.

pulmonary vein isolation

Procedure

ICE catheter placed through one of two existing 8F sheaths

Procedure

Primary outcomes

  1. number of lesions requiring ablation to obtain Electrical Isolation PV System

    Time frame: during procedure

    to assess the number of lesions requiring ablation to obtain Electrical Isolation PV system

Secondary outcomes

  1. to assess number of lesions to obtain Electrical Isolation PV system

    Time frame: during procedure

    Evaluate the time required to obtain electrical isolation of PV system

Other outcomes

  1. Safety-Cardiac perforation, emboli, fistula formation

    Time frame: during procedure

    evaluate the use of ultrasound catheter for adverse events such as cardiac perforation, emboli or fistula formation

Sponsors and collaborators

Lead sponsor

Gregory Jones

Other

Collaborators

  • Biosense Webster, Inc.

Registry information

Acronym: ICE

Important dates

Study start
2013
Primary completion
2015
Study completion
2016
First posted
Jan 7, 2014
Registry last updated
Apr 24, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.